Co-Diagnostics, Inc. announced revenue guidance for the first quarter of 2022. For the quarter, the company expected revenue in the range of $21.0 million to $22.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -5.59% | +28.57% | +1.50% |
13/05 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
09/05 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.50% | 42.23M | |
-26.77% | 16.48B | |
-43.46% | 2.79B | |
+22.46% | 1.94B | |
-12.32% | 1.46B | |
+31.49% | 1.33B | |
-16.15% | 966M | |
+1.33% | 791M | |
-31.07% | 788M | |
-25.95% | 620M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Co-Diagnostics, Inc. Announces Revenue Guidance for the First Quarter of 2022